“psoriasis”

“RECIST”

“RES”

“Revlimid”

“rheumatoid arthritis”

“R&D”

“SAE”

GLOSSARY

common,

chronic,

relapsing/remitting,

a
immune-
mediated systemic disease characterized by skin lesions
including red, scaly patches, papules and plaques, which
usually itch

Response Evaluation Criteria in Solid Tumors, a set of
published rules that define when tumors in cancer
patients improve, stay the same, or worsen during
treatment

response evaluable subtype

Lenalidomide, a derivative of thalidomide introduced in
2004 and sold under trade name Revlimid

an autoimmune disease where the body’s immune system
attacks normal joint tissues, causing inflammation of the
joints and surrounding tissues; it can also affect other
organs

research and development

serious adverse event, any untoward medical occurrence
in a patient during clinical trials that results in death, is
requires impatient hospitalization or
life-threatening,
prolongation of
existing hospitalization,
in
persistent or significant disability/incapacity, or
is a
congenital anomaly/birth defect

results

“SD”

stable disease

“second-line therapy”

treatment that is given when first-line therapy doesn’t
work, or stops working

“SLE” or “systemic lupus

erythematosus”

a systemic autoimmune disease in which the body’s
immune system attacks normal, healthy tissue and can
result in symptoms such as inflammation and swelling

“statins”

“T cell”

a group of medicines that can help lower the level of
LDL-C in the blood

a type of white blood cell which is an essential part of the
immune system

– 44 –

